Parenteral Drugs (India) reports standalone net loss of Rs 20.70 crore in the September 2016 quarter
Sales decline 69.84% to Rs 17.70 crore
Net Loss of Parenteral Drugs (India) reported to Rs 20.70 crore in the quarter ended September 2016 as against net loss of Rs 10.70 crore during the previous quarter ended September 2015. Sales declined 69.84% to Rs 17.70 crore in the quarter ended September 2016 as against Rs 58.69 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales17.7058.69 -70 OPM %-12.158.71 -PBDT-20.61-5.44 -279 PBT-25.13-10.70 -135 NP-20.70-10.70 -93Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content